ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SOPH Sophia Genetics SA

5.00
-0.08 (-1.57%)
May 03 2024 - Closed
Delayed by 15 minutes

Sophia Genetics Financial Summary

The current SOPH market cap is 326.15M. The company's latest EPS is USD -1.1295 and P/E is -4.43.

Quarter End
USD ($)
Total Revenue
Operating Income
Net Income
Year End December 30 2021 2021
USD ($)
Total Revenue 40.45M
Operating Income -71.49M
Net Income -73.68M
Quarter End
USD ($)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2021 2021
USD ($)
Total Assets 320.17M
Total Liabilities 44.77M
Total Equity 275.4M
Quarter End
USD ($)
Operating
Investing
Financing
Year End December 30 2021 2021
USD ($)
Operating -57.94M
Investing -56.93M
Financing 237.77M
Market Cap 326.15M
Price to Earnings Ratio -4.43
Price to Sales Ratio 8.06
Price to Cash Ratio 1.69
Price to Book Ratio 1.18
Dividend Yield -

Share Statistics

Shares Outstanding 65.23M
Average Volume (1 week) 29.43k
Average Volume (1 Month) 68.33k
52 Week Change 6.16%
52 Week High 7.37
52 Week Low 2.13
Spread (Intraday) 2.56 (41.03%)

Company Info

Company Name Sophia Genetics SA
Address rue du centre 172
lausanne 1025
Website https://www.sophiagenetics.com
Industry cmp processing,data prep svc (7374)

Your Recent History

Delayed Upgrade Clock